Cart
sales@molnova.com
3-Bromocytisine
CAS No. 207390-14-5
3-Bromocytisine( 3-Br-cytisine | (-)-3-Bromocytisine | (-)-9-Bromocytisine )
Catalog No. M26025 CAS No. 207390-14-5
3-Bromocytisine (3-Br-cytisine) is a potent nACh receptors agonist, (IC50s: 0.28, 0.30 and 31.6 nM for hα4β4, hα4β2, and hα7-nACh).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 188 | In Stock |
|
| 5MG | 214 | In Stock |
|
| 10MG | 309 | In Stock |
|
| 25MG | 521 | In Stock |
|
| 50MG | 733 | In Stock |
|
| 100MG | 1004 | In Stock |
|
| 200MG | 1349 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-Bromocytisine
-
NoteResearch use only, not for human use.
-
Brief Description3-Bromocytisine (3-Br-cytisine) is a potent nACh receptors agonist, (IC50s: 0.28, 0.30 and 31.6 nM for hα4β4, hα4β2, and hα7-nACh).
-
Description3-Bromocytisine (3-Br-cytisine) is a potent nACh receptors agonist, (IC50s: 0.28, 0.30 and 31.6 nM for hα4β4, hα4β2, and hα7-nACh).(In Vitro):3-Bromocytisine shows different effects on high and low ACh sensitivity α4β2 nAChRs with EC50s are 8 and 50 nM, respectively .
-
In Vitro——
-
In Vivo——
-
Synonyms3-Br-cytisine | (-)-3-Bromocytisine | (-)-9-Bromocytisine
-
PathwayOthers
-
TargetOther Targets
-
RecptorD4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number207390-14-5
-
Formula Weight269.142
-
Molecular FormulaC11H13BrN2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (371.55 mM)
-
SMILESBrc1ccc2[C@H]3CNC[C@H](C3)Cn2c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nakazawa S, et al. Behavioral and neurophysiological effects of Ro 10-5824, a dopamine D4 receptor partial agonist, in common marmosets. Psychopharmacology (Berl). 2015 Sep;232(17):3287-95.
molnova catalog
related products
-
P110
Dynamin-related protein 1 (Drp1) inhibitor, inhibits Drp1 GTPase activity. Displays no effect on dynamin 1 or other mitochondrial dynamics-related proteins. Inhibits mitochondrial fission, dysfunction and reactive oxygen species (ROS) production in vitro. Reduces programmed cell death and improves cell viability by protecting mitochondrial integrity. Reduces mitochondrial fragmentation and mitochondrial ROS production in mouse model of Parkinson's disease. Cell permeable.
-
(-)-Sparteine
Sparteine is a class 1a antiarrhythmic agent, a sodium channel blocker. The deficient debrisoquine hydroxylation of Sparteine is due to the absence of P-450IID1 protein in the livers of poor metabolizers.
-
Grosvenorin 2-glucos...
Grosvenorin 2''-glucoside
